Effect of Aliskiren on Muscle Sympathetic Nerve Activity (MSNA) in Hypertensive Patients With Chronic Kidney Disease.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Aliskiren (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 15 Jan 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 Jan 2010 Planned number of patients changed from 25 to 30 as reported by ClinicalTrials.gov.
- 13 Aug 2008 New trial record.